Built largely through a series of acquisitions over the past two decades, J&J has been legendary for its decentralized style and well-defended fiefdoms. Even within skin care, for example, it has operated separate headquarters and organizational structures for its Neutrogena brand in the Los Angeles area and its other skin-care brands in Skillman, N.J.
But now, as J&J prepares to bring Pfizer's Lubriderm into the fold, it's in the process of bringing skin-care brands into a single organization, said an executive close to the company, who believes the unit may eventually follow the company's central marketing-services organization into a Manhattan headquarters.
It's also tapped Marc E. Robinson, president of Pfizer Consumer Healthcare, to head the combined J&J-Pfizer OTC drug businesses as group chairman-consumer health. He reports to Colleen Goggins, worldwide chairman of the consumer and personal-care products group. J&J declined to comment, but executives said the newly consolidated division will incorporate the incoming Pfizer brands as well as existing J&J brands now divided among three of its companies.
Several J&J and Pfizer executives will work under Mr. Robinson, according to people familiar with the matter, including Ashley McEvoy, now general manager-McNeil Consumer Healthcare, who becomes president of U.S. OTC; Rick Rizzo, now president of Pfizer's Europe division, who will become president of J&J's international consumer-health and OTC business; and Paul Sturman, former VP-marketing of Pfizer, who will become president-consumer health care U.S. for J&J.